Antibiotic Resistance (DR) = MIC/MCC < Toxic Plasma Concentration
Generation | Spectrum | BBB Penetration | Preparations |
---|---|---|---|
First | Broad spectrum. Active mainly Against gram +ve organisms | Do not pass | Oral: Cephalexin, Cephadroxil, Cephradine; Parenteral: Cephazoline, Cephradin |
Second | Broad spectrum. Similar to 1st generation but less active on Gram +ve & more on gram –ve | Do not pass | Oral: Cefaclor, Cefuroxime; Parenteral: Cefuroxime, Cefamandole, Cefoxitin (anaerobe) |
Third | Broad spectrum similar to 2nd generation but less on gram +ve & more on Gram –ve bacilli and anaerobes | Pass | Oral: Cefpodoxime; Parenteral: Cefotaxime, Ceftriaxone, Cefoperazone, Ceftazidime |
Fourth | Similar to 3rd generation but more resistant to β- lactamase enzyme | Pass | Parenteral: Cefepime (excellent penetration to CSF) |
Feature | Imipenem | Meropenem |
---|---|---|
Spectrum | Gm-ve, Gm+ve organisms, anaerobes | Slightly more in Gm- ve and less in Gm+ve |
Beta lactamase | Resistant | Resistant |
Renal dehydropeptidase | Destroyed→ low urinary concnt. so used clinically + Cilastatin (dehydropeptidase inhibitor). | Not affected |
Side effects | Excessive levels in patients with renal failure may lead to seizures. NOT USED IN TTT OF MENINGITIS | less likely to cause seizures nausea, vomiting, diarrhea, skin rashes, and reactions at the infusion sites. |
Allergy | Patients allergic to PNCs may be allergic to carbapenems. | Patients allergic to PNCs may be allergic to carbapenems. |